The first cohort (n = 304), previously used to identify DLBCL subtypes (denoted as “Harvard”) was analyzed for exomic mutations, copy number in selected genomic regions, and BCL2/BCL6 rearrangements [88]. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.